Trial Profile

A Phase 3b Randomized, Double-Blinded, Placebo-Controlled, Multicenter, Efficacy and Safety Study of Imiquimod Cream Following Cryosurgery for the Treatment of Actinic Keratoses.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 14 Mar 2011

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Imiquimod (Primary)
Indications Actinic keratosis; Skin cancer
Focus Therapeutic Use
Sponsors Graceway Pharmaceuticals

Most Recent Events

08 Feb 2011 Results presented at the 69th Annual Meeting of the American Academy of Dermatology.
30 Sep 2010 Results have been published in the Journal of Drugs in Dermatology, according to a Graceway Pharmaceuticals media release. Results were also detailed in this media release.
30 Aug 2010 Company added in the association field and additional lead trial centre identified as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com